The treatment of benign prostatic hyperplasia includes a variety of options ranging from medication to open prostatectomy. Several newer technologies have been developed. Transurethral resection of the prostate remains the gold standard among surgical procedures for prostates less than 80 cc whereas enucleation and simple open prostatectomy are most documented for larger prostates. This review has focus on the status of treatment available in Denmark at the moment. Thorough evaluation of the patients before treatment and shared decision-making with regard to treatment options is essential.

Download full-text PDF

Source

Publication Analysis

Top Keywords

open prostatectomy
8
[not available]
4
treatment
4
available] treatment
4
treatment benign
4
benign prostatic
4
prostatic hyperplasia
4
hyperplasia includes
4
includes variety
4
variety options
4

Similar Publications

: Prostate cancer (PCa) is the most frequent neoplasia in the male population. According to the International Society of Urological Pathology (ISUP), PCa can be divided into two major groups, based on their prognosis and treatment options. Multiparametric magnetic resonance imaging (mpMRI) holds a central role in PCa assessment; however, it does not have a one-to-one correspondence with the histopathological grading of tumors.

View Article and Find Full Text PDF

Introduction: Transurethral resection of the prostate (TURP) is the gold standard surgical treatment to lower urinary tract symptoms and benign prostatic obstruction (LUTS/BPO). Although it has been proven to have substantial efficacy in improving functional outcomes, it has shown a high incidence of complications, including transurethral resection syndrome, massive bleeding, urinary incontinence and sexual dysfunction. High-frequency irreversible electroporation (H-FIRE) is a novel non-thermal ablation technique that delivers pulsed high-voltage but low-energy electric current to the cell membrane, thereby leading to cell death.

View Article and Find Full Text PDF

Aim: Robotic total mesorectal excision (TME) with resection of adjacent organs has been increasingly used for locally advanced rectal cancer; however, few studies have focused on robotic TME with partial prostatectomy. Therefore, this study aimed to demonstrate the advantages of robotic TME with partial prostatectomy compared with open surgery for rectal cancer.

Method: This retrospective cohort study examined consecutive patients with rectal cancer who underwent robotic or open TME with partial prostatectomy at a high-volume center in Japan from April 2003 to March 2022.

View Article and Find Full Text PDF
Article Synopsis
  • The study assesses surgeon efficiency when transitioning from laparoscopic to robotic-assisted inguinal hernia repair across multiple centers and surgeons.
  • Experienced surgeons with no prior robotic experience participated, measuring efficiency by procedure durations and outcomes post-surgery.
  • The results show that surgeons improved their efficiency over time, especially in unilateral repairs during the mid-phase of the study, although variations existed between individuals and factors like practice patterns and external circumstances impacted the results.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the long-term physical performance and activity levels of older men who have survived radical prostate cancer compared to matched controls.
  • The research included 109 men aged 70 and older who had received robotic surgery or radiation therapy, and their results were compared to 327 men from the general population.
  • Overall, survivors showed similar physical performance and activity levels as controls, with only minor differences in grip strength and balance that might not be clinically significant, indicating that cancer treatment likely did not adversely affect their functional status.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!